In the PM-2 K+CD14+ and PM-2 K+CD14− subsets of macrophage-like cells, the percentages of M1-, M2a-, M2b-, and M2c-like macrophages were not significantly different between patients with HER2-positive and those with HER2-negative breast cancer (Additional file 2). The gene discussed is CD14; the disease is breast cancer.